ATOMOS LIMITED — Capital/Financing Update 2024

Apr 22, 2024

ACN 139 730 500

700 SWANSTON STREET CARLTON VIC 3053

==> picture [48 x 40] intentionally omitted <==

23 April 2024

Dear Shareholder

Atomos Limited – NON-RENOUNCEABLE PRO-RATA ENTITLEMENT OFFER

Atomos Limited (ACN 139 730 500) ( Atomos or the Company ) is undertaking a 1 for 1 non-renounceable pro rata entitlement offer of ordinary shares ( Entitlement Offer Shares ) at an offer price of A$0.02 ( Offer Price ) per Entitlement Offer Share to raise up to A$8 million, with one (1) free quoted option for every two (2) Entitlement Offer Shares (exercisable at A$0.03 on or before 30 November 2025) applied for and issued ( Entitlement Offer Options ) ( Entitlement Offer ).

We are writing to you as an eligible shareholder, entitled to participate in the Entitlement Offer.

The Prospectus and your Personalised Entitlement and Acceptance Form can be accessed at: https://www.investorserve.com.au/.

The Prospectus can also be accessed via the Company’s website https://atomos.com/.

A copy of the Company’s target market determination ( TMD ) that has been prepared in accordance with the design and distribution obligations under the Corporations Act 2001 (Cth) in connection with the offer of the Entitlement Offer Options is also available to view alongside the Prospectus, and is available to view at the Company’s website.

The Offer closes at 5:00pm (AEST) on Monday, 13 May 2024.

The number of Entitlement Offer Shares and attaching Entitlement Offer Options for which you are entitled to apply for under the Entitlement Offer ( Entitlement ) is shown on your Personalised Entitlement and Acceptance Form.

Eligible shareholders who wish to subscribe for additional securities above their Entitlement are invited to do so by applying for any additional securities under the Personalised Entitlement and Acceptance Form ( Oversubscription Application ). However, securities applied for under an Oversubscription Application will only be made available if there is a surplus of Entitlements not taken up pursuant to the Entitlement Offer. To the extent that the amount of securities applied for under Oversubscription Applications exceeds the amount of securities available, Oversubscription Applications will be scaled-back on a pro-rata basis.

Applications

To access the online system at https://www.investorserve.com.au/, you will need to provide your Securityholder Reference Number (SRN) or Holder Identification Number (HIN) and postcode and follow the instructions provided including making payment by BPAY ® for the securities you wish to subscribe for.

If you are unable to access https://www.investorserve.com.au/, please contact the Company’s share registry on 1300 737 760 (in Australia) or +61 2 9290 9600 (outside Australia).

ACN 139 730 500

700 SWANSTON STREET CARLTON VIC 3053

==> picture [48 x 40] intentionally omitted <==

Actions required by Eligible Shareholders

There are a number of actions you may take:

• accept your full Entitlement;

• accept your full Entitlement and apply for additional securities;

• accept part of your Entitlement; or

• if you do not wish to accept all or part of your Entitlement, you are not obliged to do anything.

Key dates for the Entitlement Offer

Event	Date
Record Date for determining Entitlements	7:00pm (AEST) onThursday, 18 April 2024
Entitlement Offer opening date	Tuesday, 23 April 2024
Entitlement Offer closing date	5:00pm (AEST) onMonday, 13 May 2024
Announcement of Entitlement Offer results	Wednesday, 15 May 2024
Issue date and lodgement of App 2A with ASX applying forquotation of the Entitlement Offer Shares and EntitlementOffer Options	Prior to 12:00pm (AEST) onFriday, 17 May 2024
Quotation of Entitlement Offer Shares and EntitlementOffer Options on a normal settlement basis*	Monday, 20 May 2024
Dispatch of holding statements in respect of EntitlementOffer Shares and Entitlement Offer Options*	Wednesday, 22 May 2024

*Trading of the Entitlement Offer Shares and Entitlement Offer Options is conditional upon the Company’s shares being re-instated to trading. ASX has indicated that it sees no reason why the securities of the Company should not be reinstated to quotation subject to the satisfaction of certain conditions. Please see section 3.16 of the Prospectus for more information.

You should read the entire Prospectus carefully and seek professional advice before deciding whether to invest in the Entitlement Offer.

If you have any queries concerning the Entitlement Offer, please contact your financial adviser or myself at cosec@atomos.com.

Yours sincerely

VanessaChidrawi

Vanessa Chidrawi Company Secretary